Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. - Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS (Current opinion in investigational drugs (London, England : 2000), 2008)